DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The purpose of this study is to evaluate whether a novel decision support tool called PRIME (Preference Reporting to Improve Management and Experience), which combines values-elicitation with tailored feedback to patients and providers, improves patient-reported values-concordance of initial treatment decisions compared to usual care.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek co najmniej 60 lat
- •Pierwsza wizyta w klinice chorób krwi lub klinice przeszczepów szpiku
- •Zgoda na udział w badaniu i przetwarzanie danych zdrowotnych
- •Zdolność do uczestniczenia w procedurach badania
✗ Disqualifies
- •Zaburzenia pamięci, problemy psychiczne lub zaburzenia psychiatryczne utrudniające zrozumienie i wyrażenie zgody
Simplified criteria — AI translation
Trial details
- Minimum age
- 60 Years
- Last updated (source)
- August 14, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
Lineberger Comphrehensive Cancer Center at University of North Carolina
Chapel Hill, United States
Trial contact
Madisyn L Parker
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/5/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.